Bevacizumab BS IV infusion 400mg “Nichi-Iko”, manufactured by Nichi-Iko, contains Bevacizumab (genetical recombination) [Bevacizumab follow-up 3]. This monoclonal antibody works by inhibiting VEGF-A, a growth factor that promotes new blood vessel formation, thereby reducing blood supply to tumors. It is provided as 400mg in 16mL per bottle, with YJ code 4291461A2028.
Bevacizumab BS IV infusion 400mg “Nichi-Iko”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →